Article Cited by others


Understanding prostate-specific antigen dynamics in monitoring metastatic castration-resistant prostate cancer: implications for clinical practice

Mizokami Atsushi, Izumi Kouji, Konaka Hiroyuki, Kitagawa Yasuhide, Kadono Yoshifumi, Narimoto Kazutaka, Nohara Takahiro, Bahl Amit K, Namiki Mikio

Year : 2017| Volume: 19| Issue : 2 | Page no: 143-148

   This article has been cited by
1 The U Shape of Prostate-specific Antigen and Prostate Cancer-specific Mortality in High-grade Metastatic Prostate Adenocarcinoma
Jun Wang,Mierxiati Abudurexiti,Ning Shao,Yu Wei,Yao Zhu,Ding-wei Ye
European Urology Focus. 2018;
[Pubmed]  [Google Scholar] [DOI]
2 HoxB13 mediates AR-V7 activity in prostate cancer
Héctor I. Navarro,Andrew S. Goldstein
Proceedings of the National Academy of Sciences. 2018; 115(26): 6528
[Pubmed]  [Google Scholar] [DOI]
3 TRIM16 transcription factor in prostate cancer
L. V. Spirina,A. ?. Gorbunov,I. V. Kondakova,E. ?. Slonimskaya,?. A. Usynin,N. V. Tarasenko
Bulletin of Siberian Medicine. 2018; 17(3): 122
[Pubmed]  [Google Scholar] [DOI]
4 Biomarkers for the Management of Castration-Resistant Prostate Cancer: We Are Not There Yet
Daniel P. Petrylak,E. David Crawford
Targeted Oncology. 2017;
[Pubmed]  [Google Scholar] [DOI]
5 Therapies for castration-resistant prostate cancer in a new era: The indication of vintage hormonal therapy, chemotherapy and the new medicines
Atsushi Mizokami,Yoshifumi Kadono,Yasuhide Kitagawa,Kouji Izumi,Hiroyuki Konaka
International Journal of Urology. 2017;
[Pubmed]  [Google Scholar] [DOI]


Read this article